688607: Careray Digital Medical Technology Co.Ltd(688607) explanation and verification opinions of the board of supervisors on the publicity of the list of incentive objects of the restricted stock incentive plan in 2022

Careray Digital Medical Technology Co.Ltd(688607) board of supervisors

Explanation and verification opinions on the publicity of the list of incentive objects of the restricted stock incentive plan in 2022

Careray Digital Medical Technology Co.Ltd(688607) (hereinafter referred to as "the company") held the fifth (Interim) meeting of the second board of directors and the fifth (Interim) meeting of the second board of supervisors respectively on January 20, 2022, deliberated and adopted the proposal on the company's restricted stock incentive plan in 2022 (Draft) > and summary and other relevant proposals, For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on January 21, 2022 Relevant announcements disclosed on.

According to the relevant provisions of the measures for the administration of equity incentive of listed companies, the company will internally publicize the list of incentive objects of the restricted stock incentive plan in 2022 (hereinafter referred to as the "incentive plan"), and the board of supervisors will verify the relevant information of incentive objects in combination with the publicity and give verification opinions. The relevant contents are as follows: I. publicity

Name and incentive content of the position.

Publicity time: January 21, 2022 to January 30, 2022.

Publicity method: posted inside the company.

Feedback method: during the publicity period, employees of the company (including subsidiaries) can feed back relevant objections to the board of supervisors through telephone, e-mail and on-site communication, and the board of supervisors is responsible for recording relevant information.

Publicity result: the board of supervisors did not receive any objection at the expiration of the publicity period.

2、 Verification

The board of supervisors checked the list of incentive objects, the ID cards of incentive objects, the labor contracts or employment agreements signed between incentive objects and the company (including subsidiaries), and the employment status of incentive objects in the company (including subsidiaries).

3、 Verification opinions

In combination with the publicity and verification, the board of supervisors issued the following verification opinions:

1. The basic information of the incentive object is true, and there is no falsehood, intentional concealment or major misunderstanding. 2. The incentive object meets the qualification of the company law, the securities law and other regulations, meets the conditions of the incentive object specified in the Listing Rules of science and Innovation Board of Shanghai Stock Exchange, and the subject qualification is legal and effective.

3. The incentive objects include the company's directors, senior managers (excluding independent directors and supervisors) and other personnel that the company's board of Directors considers should be encouraged, which is in line with the scope of incentive objects specified in the company's restricted stock incentive plan 2022 (Draft) and the implementation purpose of this incentive plan.

4. The incentive objects include the actual controllers of the company, Mr. Jiang Liu (Liu Jianqiang) (American nationality) and Mr. Gao Peng. Among them, Mr. Jiang Liu (Liu Jianqiang) is currently the chairman and general manager of the company; Mr. Gao Peng is currently a director and deputy general manager of the company. As the core leaders of the company, the above-mentioned personnel are the core technicians of the company, which have a decisive influence on the operation, management and development strategy of the company.

In addition, the incentive objects also include Mr. Gao Zihuan, the son of Mr. Gao Peng, the actual controller of the company, and 8 other foreign incentive objects of the company (including subsidiaries). These personnel groups all work in key positions of the company (including subsidiaries) and play an important role in operation and management, technology research and development, business development and so on.

Therefore, it is reasonable and necessary for the incentive plan to take the above personnel as the incentive object, which is in line with the actual situation and development needs of the company.

Careray Digital Medical Technology Co.Ltd(688607) board of supervisors February 6, 2022

- Advertisment -